Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Dynatronics Awarded CE Mark Approval for Its Solaris Products | ||
| By: PR Newswire Association LLC. - 27 Jul 2015 | Back to overview list |
|
SALT LAKE CITY, July 27, 2015 /PRNewswire/ -- Dynatronics Corporation (NASDAQ: DYNT) today announced it has received CE Mark approval for its Solaris therapeutic modality products. This approval allows the company to sell these products in Europe and many other countries around the world. "Receiving the CE Mark represents the achievement of an important milestone for our international sales efforts," stated Kelvyn H. Cullimore Jr., president and CEO of Dynatronics. "Over the past several years, we have expanded our distribution network into China, Japan, Mexico, Portugal, Singapore, Malaysia and several other countries. Now, with the CE Mark, we can further expand throughout Europe and into areas of the world that recognize and require this distinguished mark of quality. "Over the next year, we expect our international sales growth to accelerate," Cullimore added. "Our core therapeutic modality products offer a number of technological advantages already popular among physical therapists and athletic trainers practicing in the United States. The CE Mark approval will allow us to extend our geographical reach and become a provider of these products on a global basis. "With our recent capital infusion, we're better positioned to develop the sales resources necessary to capitalize on these international opportunities." Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical markets. More information regarding Dynatronics is available at www.dynatronics.com. This press release contains forward-looking statements. Those statements include references to the company's expectations and similar statements. Actual results may vary from the views expressed in the forward-looking statements contained in this release. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, competitive factors, inventory risks due to shifts in market demand, market demand for the company's products, availability of financing at cost-effective rates and the risk factors listed from time to time in the company's SEC reports.
SOURCE Dynatronics Corporation 
|
||
|
||
 | Back to overview list | |